Verastem
VSTM
135 hedge funds and large institutions have $246M invested in Verastem in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 12 closing their positions.
315% more call options, than puts
Call options by funds: $1.96M | Put options by funds: $472K
42% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 12
37% more capital invested
Capital invested by funds: $179M → $246M (+$66.9M)
11% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 38
4% more funds holding
Funds holding: 130 → 135 (+5)
0.7% more ownership
Funds ownership: 4.14% → 4.84% (+0.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$16M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$7.99M |
| 3 |
Two Sigma Advisers
New York
|
+$4.14M |
| 4 |
Two Sigma Investments
New York
|
+$3.8M |
| 5 |
Renaissance Technologies
New York
|
+$2.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$3.98M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$896K |
| 3 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$536K |
| 4 |
ACM
Altium Capital Management
New York
|
-$371K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$370K |
VSTM Hedge Fund Activity: Q1 2021 in Review
135 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Verastem (VSTM) for Q1 2021, worth a combined $246M — up 37% from $179M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new VSTM positions and 12 closed out — a net gain of 5 holders — while 42 added to existing stakes and 38 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $16M. The largest seller was Graham Capital Management, exiting entirely with an estimated $3.98M sold.
- 135 institutional investors held Verastem (VSTM) as of Q1 2021, up from 130 in Q4 2020.
- Funds reported $246M of Verastem stock for Q1 2021, up 37% quarter-over-quarter.
- 17 funds opened new Verastem positions in Q1 2021 and 12 closed out, a net change of +5 holders.
- The largest Verastem buyer in Q1 2021 was Baker Bros. Advisors, an estimated $16M added.
- The largest Verastem seller in Q1 2021 was Graham Capital Management, an estimated $3.98M sold.
Based on aggregated 13F filings for Q1 2021.